US 6750239
Pyrazole-derived kinase inhibitors and uses thereof
expired A61PA61P1/16A61P17/06
Quick answer
US patent 6750239 (Pyrazole-derived kinase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P1/16, A61P17/06, A61P19/00, A61P21/00